Inside informationEnglish
GENFIT Announces U.S. Medicare Coverage and Future Reimbursement for NASHnext®, a Non-Invasive Diagnostic Technology to Identify Patients with At-Risk MASH
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Genfit
- Filed
- 02/07/2026, 18:05
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 110938_20260702